@hoardyi
In a twist for the books, Eli Lilly, the company behind popular weight loss drugs, slammed folks using GLP-1s without an obesity diagnosis at the 2024 Oscars. Fast forward to 2025, and they're switching gears to take on competitors without FDA approval. Stay tuned!